Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006089
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2000-08-03
Brief Title:
Trastuzumab in Treating Patients With Stage III Stage IV or Recurrent Endometrial Cancer
Sponsor:
Organization:
National Cancer Institute NCI